Swedish regional innovation intermediary specializing in pre-commercial procurement and cross-sector collaboration for healthcare and industry.
Innovation Skåne AB is a regional innovation intermediary based in Lund, Sweden, operating within the Öresund cross-border innovation corridor. Their core work involves facilitating collaboration between sectors that don't typically work together — connecting aerospace, biotech, ICT, energy, and medical device industries to generate new solutions. More recently, they have moved into managing pre-commercial procurement (PCP) processes on behalf of public healthcare buyers, acting as a procurement intermediary that sources innovative integrated care solutions. They sit at the intersection of public sector needs and private sector innovation capacity, making them a connector rather than a technology developer.
Carematrix PCP (2021-2025) involved coordinating a pre-commercial procurement process for integrated care solutions targeting multimorbidity, with Innovation Skåne acting as the lead coordinator.
Cross4Health (2017-2020) focused explicitly on generating collaboration among Aerospace, Biotechnology, ICT, Energy, and Medical Devices sectors.
Carematrix PCP addressed the specific challenge of integrated care for patients with multimorbidity (PMM), positioning Innovation Skåne in the complex care coordination space.
Across both projects, Innovation Skåne played a bridging role — between sectors in Cross4Health and between public buyers and technology suppliers in Carematrix PCP.
In their first H2020 project (2017-2020), Innovation Skåne focused on horizontal cross-sector collaboration — bringing together very different industries to explore technology transfer and shared innovation opportunities, without a specific application domain as the target. By their second project (2021-2025), their focus had narrowed sharply and deepened: they moved into the healthcare domain with a specific mandate around integrated care for multimorbid patients, coordinating a formal pre-commercial procurement process. The shift suggests a strategic choice to develop specialized procurement facilitation expertise in health, rather than remaining a generalist cross-sector broker.
Innovation Skåne appears to be positioning itself as a specialist PCP intermediary in public health procurement, a niche that requires both procurement process expertise and sector knowledge — future collaborations are most likely to involve them in roles coordinating buyer-side consortia for healthcare innovation challenges.
Innovation Skåne has experience on both sides of the coordinator/partner divide: they joined Cross4Health as a participant in a multi-sector consortium, then stepped up to lead Carematrix PCP as the coordinator. Their consortium footprint is modest — 12 unique partners across 7 countries over two projects — suggesting they work in focused, purposeful teams rather than large open networks. This profile makes them a practical partner for consortia that need a capable intermediary lead without the overhead of a large institution.
Innovation Skåne has built connections with 12 unique consortium partners spanning 7 countries, reflecting a genuinely European reach despite being a regionally anchored organization. Their network likely bridges Nordic public sector actors with broader European health and technology partners.
Innovation Skåne occupies a specific niche that few organizations can fill: a regional innovation agency with hands-on experience managing pre-commercial procurement processes in healthcare — a technically demanding, procedurally complex task that most research organizations avoid. Based in Lund, they sit at the heart of the Öresund region, one of Europe's most concentrated life science and medtech clusters, giving them direct access to both academic research capacity and industry partners. For a consortium needing a credible, procedurally experienced coordinator on the buyer side of a healthcare PCP or innovation procurement, they represent a practical and regionally well-connected option.
